FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval
Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug Application (NDA) of TNX-102 SL, a novel ... Read More
Shocking Mpox surge: Over 15,000 cases in Africa—WHO sounds alarm
Africa is facing a significant health crisis as the mpox outbreak has surged, prompting the World Health Organization (WHO) to convene an urgent meeting to ... Read More
Tonix Pharmaceuticals gets FDA clearance for TNX-1900 phase 2 trial in chronic migraineurs
Tonix Pharmaceuticals is set to launch a phase 2 clinical trial of TNX-1900 (intranasal potentiated oxytocin) in migraine patients after getting clearance from the US ... Read More